Atossa Therapeutics News and Activities

Atossa Therapeutics is a company listed under the stock ticker ATOS (US).

View the org chart displaying its 17 main executives

Most searched biographies at Atossa Therapeutics

• Steven Quay, Chairman of the Board and Chief Executive Officer
• Jonathan Finn, Director
• Shu-Chih Chen, Director

Popular executive movements at Atossa Therapeutics

• Kathy Puyana Theall has joined the company as Medical Director, Breast Oncology  (posted on March 22 2026).
• Adebola Giwa has joined the company as Medical Director, Rare Diseases  (posted on March 22 2026).
• Mark Daniel has joined the company as Chief Financial Officer  (posted on October 16 2025).

Click here to view some more movements at Atossa Therapeutics

Create your alert
to follow the executive moves at Atossa Therapeutics.

Atossa Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Atossa Therapeutics

• News Releases - Atossa Therapeutics
• Investors – Atossa Therapeutics

Social media about Atossa Therapeutics

• Atossa Therapeutics on Wikipedia, Google News & Yahoo Finance
• Atossa Therapeutics on LinkedIn, X (Twitter) & YouTube